COMPARING BLOOD PRESSURE CONTROL TARGETS GLOBALLY: AN ANALYSIS OF THE MAY MEASUREMENT MONTH 2022 CAMPAIGN IN 60 COUNTRIES

Thomas Beaney,Gabriele Kerr,Markus Schlaich,Aletta Schutte,George Stergiou,Neil Poulter

DOI: https://doi.org/10.1097/01.hjh.0001019544.52130.ba

IF: 4.9

2024-05-01

Journal of Hypertension

Abstract:Objective: Many contemporary hypertension guidelines recommend controlling blood pressure (BP) to less than 130/80 mmHg in most people, but it is unclear how control rates compare globally to the hitherto ubiquitous control target of 140/90 mmHg. In this analysis, we compare global and regional BP control rates based on targets of 140/90 mmHg versus 130/80 mmHg from the latest May Measurement Month 2022 (MMM22) campaign, an opportunistic screening campaign which aims to raise awareness of BP. Design and method: In MMM22, adults aged 18 years or over were screened via convenience sampling in 60 countries using a single standardised protocol. Three seated BP measurements were taken, and a questionnaire was administered collecting information including demographics, co-morbidities and antihypertensive medication use. Hypertension was defined as systolic BP 140 mmHg or more, and/or diastolic BP 90 mmHg or more, based on the average of the second and third BP readings, or the taking of antihypertensive medication. Multiple imputation using chained equations was used to estimate BP readings, where missing for any participant. Results: A total of 765,718 participants were screened during MMM22, of whom 282,488 (36.9%) were hypertensive. Of those with hypertension 51.4% were on antihypertensive medication, of whom 52.7% were taking only a single drug. Of those on antihypertensive medication, 54.2% had BP <140/90 mmHg and 28.2% had BP <130/80 mmHg. Of all hypertensives, 27.8% had BP <140/90 mmHg and 14.5% had BP <130/80 mmHg. There were large differences between regions, ranging from 13.5% of those on medication being controlled to <130/80 mmHg in South-East Asia and Australasia, to 37.4% in Europe. Conclusions: MMM22 identified significant numbers of people worldwide with inadequately treated hypertension. Of those treated for hypertension, only half were controlled to <140/90 mmHg and less than one third to the stricter target of <130/80 mmHg. Most of those on antihypertensive medication were prescribed only a single drug class, highlighting the scope for achieving better control using antihypertensive drug combinations as recommended by current guidelines.

peripheral vascular disease